Assessments Frequently Asked Questions

Running assessments

Q: How long does an Assessment take to run?
A: Most Assessments complete within approximately 15-30 minutes, depending on the volume of data available for the asset and the complexity of the connected data sources. You will be notified when the Assessment is ready to review.

Q: Can I cancel an Assessment while it is running?
A: Yes. Click the Cancel Assessment button at any time while the Assessment is in progress. A cancelled Assessment will not be saved or recorded.

Q: When should I re-run an Assessment?
A: Assessment results are a static snapshot based on the data available at the time the Assessment was run. You should re-run when new documents have been uploaded or synced from the VDR or you want to validate findings against an updated or expanded data set. Click Re-run Assessment from the Drug Assessment tab to generate a new snapshot. Previous results are retained for reference.

Interpreting results

Q: What are domains?
A: Domains are the analytical categories Prudentia applies to every Assessment: each domain represents a distinct area of scientific, clinical, or regulatory analysis. Some domains are stage-dependent and will only appear when the asset has reached the relevant phase of development. Each domain is designed to be reviewed by the appropriate expert on your team: IP and Legal domains by BD and legal leads, Discovery and Biomarker domains by R&D experts, and CMC domains by chemistry and manufacturing experts.

Q: What does "Not found" mean in an Assessment output?
A: "Not found" means the pipeline conducted a thorough search and could not verify the data point from any authoritative source.

Q: Can I modify the risk level assigned to a domain?
A: Yes. Authorized users can adjust the risk level for any domain category based on their expert judgment or new context that has emerged through diligence. All risk level changes are auditable: the record of who changed what, and when, is preserved in the Change Log.

Q: How do Assessment findings connect to the Valuation & Risk Simulator?
A: When a domain finding leads your team to adjust an Impacted Parameter, that adjusted value is automatically carried over into the Valuation & Risk Simulator as the Drug Assessment Value. It appears alongside the industry benchmark so you can see exactly what the finding implies for your valuation model. This is the direct link between the scientific analysis in Prism and the financial modelling in the VRS.